Infection with poliomyelitis virus gives rise to complement-fixing (C-F) antibodies which may be detected with antigens prepared either from the brains of infected mice or tissue culture fluids, as shown with Type II by Casals et al."' and with all three types by Svedmyr et al.' These workers used sufficient antigen in each test to obtain maximum sensitivity. With this antigen concentration the presence of antibody could generally be detected within the first week after onset of the disease, but the sera usually gave similar C-F titers against antigens of the three types of poliomyelitis virus regardless of the type involved in the infection. It has now been found possible to obtain a more specific reaction in patients with the disease by a method in which not more than one conventional unit of antigen is used per test. In order to detect fixation with this low level of antigen, dilutions of serum were titrated at several complement concentrations by the plate method of Fulton and Dumbell.'
METHODS AND MATERIALS
The general technique of the plate C-F method as used in this laboratory has been described previously.' This method has already been used in poliomyelitis work by Svedmyr et one-fourth of a conventional unit. Fluids containing less than two units per 20 cm. drop could be concentrated by centrifugation at 40,000 R.P.M. (about 106,000 x gravity) for two hours, and resuspension of the pellet in a small volume of diluent, but this was usually not necessary. Occasional lots were found anticomplementary in which case they could often be made serviceable by heating at 560 C. for 30 minutes.9 Heating the antigens had the added advantage of rendering them non-infectious.
Sera were titrated with two minimal units of antigen per test drop against three concentrations of complement. The titer of a serum was taken as the highest dilution to fix more than one minimal unit of complement in excess of the amount fixed by either serum or antigen control. (For example in the Type I titration illustrated in Figure 1 , the greater amount of fixation is in the antigen control. The highest serum dilution to give fixation of more than one unit in excess of this control is 1: 16 and the serum titer is 16.) As well as the titer, it was possible to determine from such a twodimensional titration, the total amount of complement fixed. This character of the serum, its azndity for complement, is partially independent of the titer. An expression of the avidity dependent on both the titer of the serum and the amount of complement fixed was calculated as follows: (a) the score for the degree of fixation was summed for all serum dilutions up to the titration endpoint, and from this was subtracted (b) the number of dilutions tested up to the endpoint, multiplied by the sum of the fixation score for the control showing the greater degree of fixation. Serum scores, (a) above, were calculated for the titrations with two, three, and four units of complement and the control scores (b) for one, two, and three units and thus the avidity was positive only when more than one unit of complement was fixed. (In the Type I example again, the value for (a) is 22, and for (b) the subtrahend, based on the antigen control, is 6 x 3 or 18. The avidity score is therefore four. The avidity for the Type III titration in Figure  1 is ten, although the titer is only eight.) With the human sera the avidity was found more reproducible and showed fewer erratic variations between serial serum samples than the simple serum titer. Sera from poliomyelitis patients.* Acute and convalescent sera from 49 patients diagnosed as poliomyelitic were tested for C-F antibodies against the three types of antigen. These sera had previously been tested for neu-tralizing antibody, and stools from most of the patients had been tested for virus."1 Both Type I and II viruses, but no Type III virus had been isolated from the stools. Some examples of the results are given in Table 2 , and the types of response found in all the sera are classified in Table 3 by type of disease. All patients from whom virus was isolated had homotypic neutralizing antibodies in their serum and frequently this was already at high titer at the time of the first serum collection (0-14 days after onset), e.g. No. 83.
In contrast homotypic C-F antibodies were rarely detectable in the first serum sample by the method which has been described. Of the 40 patients studied from whom virus was isolated only three (2 Type I, 1 Type II) had demonstrable homotypic C-F antibodies at the time the first specimen was collected, 0-14 days after onset. In six cases the antibodies first became demonstrable in the third specimen more than 30 days after onset. More heterotypic responses were found in the neutralizing than in the C-F antibodies. There was no significant difference in the response of nonparalytic and paralytic patients regardless of whether infected with Type I or II viruses.
On the basis of the findings of Casals, Svedmyr, and their co-workers,2" it was expected that the highest titers of C-F antibody would be found in the sera collected in the first few weeks after onset. However, in the present study homotypic C-F antibody was rarely found before seven days after the onset of the disease and often increased after the third week. Because of this it was possible to demonstrate an increase in titer more frequently than might otherwise have been the case. On the other hand it was not possible with this method to demonstrate such a rise until some weeks after the individual had become sick.
The above investigators had found that many persons infected with Type I poliomyelitis developed C-F antibodies against Type II antigen. Yet in our study only one individual infected with Type I virus showed a Type II C-F response, nor did the reverse heterologous response, Type I C-F antibodies in Type II infection, occur more frequently. These differences between the results of our own studies and those from the two other laboratories appear to be due to the smaller amounts of antigen used in the present work. Casals used 8 to 16 units of antigen in each test and Svedmyr an approximately equivalent amount, whereas the amount of antigen used in our study was not more than one conventional unit. Serum samples from poliomyelitis patients have been exchanged with Dr. John F. Enders and the results obtained by the method described in the present report proved more specific than those obtained with concentrated antigens.! Sera from children inoculated with formalinized Type I virus. The details of this experiment"' will be reported elsewhere; here we merely wish to call attention to the application of the complement fixation test to this type of investigation. Thirty apparently healthy children aged 12 to 17 were tested for C-F antibodies at the time of inoculation and 3 and 20 weeks after inoculation with a formalin-inactivated Type I virus preparation, similar to that used by Salk.7 At the time of inoculation Type I C-F antibodies were not present at a detectable level in any individual, and Types II and III antibodies were each present in only one individual. The changes found are given in Tables 4 and 5 . Where antibodies appeared, they reached a peak titer of eight or greater in all but three instances. The responses in this group occurred, with but three exceptions, only against those types with which there had been previous experience as indicated by the neutralization tests that had been made before inoculation. Two of the three exceptions occurred in one individual where Types I and II antibodies appeared in the 20-week sample. The findings in healthy children inoculated with formalin inactivated virus were in marked contrast to those in poliomyelitic patients reported above. In the latter the response was usually only homotypic with the type of virus causing the infection. In the "vaccine" study where all the responses were caused by Type I virus material the antibodies to the three types of virus responded similarly. The Type III response was somewhat weaker than the Types I and II reaching lower maximal titers (median for Type III was 8; for Types I and II, 32) and falling off more rapidly. Table 5 shows that the presence of Type I neutralizing antibody had no significant effect on the probability of a Type II C-F response and vice versa. The Type III C-F response was also independent of Types I and II neutralizing antibodies, and Types I and II C-F responses of Type III neutralizing antibodies, but to have included these combinations would have overburdened the table. The reason for the contrasting nonspecificity of the response in the group of children in whom antibodies were stimulated artificially as compared to the response in the natural infections, has not been found as yet.
SUMMARY
A complement fixation test for poliomyelitis which uses minimal quantities of complement and antigen has been described and its application noted in two phases of poliomyelitis investigations: serodiagnosis of infection and antibody response to "vaccination": (i) Results of tests for C-F antibodies for the three types of virus are reported on specimens obtained from 49 poliomyelitis patients. The results show a homotypic C-F titer r-ise in 90% of the patients from whom virus was isolated, and a heterotypic rise in 10%.
(ii) Sera from 30 children before and after inoculation with formalininactivated Type I virus were tested for C-F antibodies. Of these, 60%o showed a post-inoculation increase in Type I, II, or III antibodies. Some showed C-F responses to antibodies of more than one type. Nearly all of the increases occurred in individuals who possessed pre-inoculation neutralizing antibodies.
